As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...